TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›NHTC
NHTC logo

NHTC

NATURAL HEALTH TRENDS CORP

Next earnings Jul 28, 2026

Last earnings -0.7% on 2026-04-29

Sell
$1.84
▲ +7.94%
$1.84▼ -50.58%
over 1Y
L $1.55H $4.27
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+7.9%
1W+7.9%
1M-28.9%
3M-32.8%
YTD-36.8%
1Y-50.6%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Sell
Quality
D
Valuation
Fair value
Filings
Flagged
Sell
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••

A melting-ice-cube direct seller: statistically cheap but shrinking, cash-burning, and paying a dividend it can no longer afford.

Revenue $39.8M · FY2025

NHT Global is in a multi-year secular decline dressed up as a value stock. Revenue has fallen every year from $60.0M (FY2021) to $39.8M (FY2025, -7.4% YoY), and FY2025 finally tipped into a net loss of -$882K with a -$1.81M operating loss — the first red ink after four profitable years. The MD&A names the cause plainly: active members dropped to 26,650 from 30,870 (down ~14%), and the company itself flags 'our continuing loss of a significant number of members is adversely affecting our business.' A 73.5% gross margin can't save a shrinking top line when the sales force is eroding.

The balance sheet looks superficially safe — $23.4M equity, no meaningful debt (liabilities/equity 0.64x), current assets $34.2M vs. $13.7M current liabilities — but the cash statement tells the real story. Operating cash flow swung to -$6.00M (down 78% YoY) and cash was cut roughly in half to $6.81M. Then the Feb 2026 subsequent event drained it further: the company bought back the founder Broady family trusts' 2,935,227 shares (25.5% of the company) at $2.00 for ~$5.9M in cash 'from existing cash on hand,' leaving well under $1M of the reported year-end balance behind a business that is still burning. Meanwhile it paid $9.21M in dividends in FY2025 — more than half the entire $15.7M market cap — against negative earnings. That dividend is mathematically unsustainable and, in my view, the most likely thing to be cut.

Is NHTC a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Bear put spread~60d expiry
  • Long put 2 @ ~0.34 est
  • Short put 1.5 @ ~0.09 est
debit $25max +$25max −$25BE 1.75

SELL verdict, defined risk: profits into weakness down to the short strike; max loss is the net debit.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$60.0M$49.1M$43.9M$43.0M$39.8M
Gross profit$45.0M$36.5M$32.7M$31.8M$29.3M
Operating income$1.57M-$270K-$1.67M-$1.30M-$1.81M
Net income$1.08M$313K$568K$572K-$882K
Diluted EPS$0.09$0.03$0.05$0.05-$0.08
Net margin1.8%0.6%1.3%1.3%-2.2%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$8.93M
EV / EBITDA—
EV / Sales0.2
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-5.6%
FCF yield-38.5%

Quality & risk

ROIC (est.)-6.1%
Free cash flow-$6.07M
Total debt—
Net cash$6.81M
Altman Z-Score0.82 distress
Piotroski F-Score3/8

Capital returns

Buyback yield0.0%
Dividend yield (est.)58.5%
Shareholder yield58.5%
Shares Δ YoY-25.5%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has skewed negative — read the flagged items.
  1. 8-K Officer / director change2026-05-07

    Annual meeting vote results; board/officer change reported (items 5.02, 5.07)

  2. 8-K Earnings results2026-04-29

    Q1 2026 10-Q: revenue pressure persists after FY2025 loss

  3. 10-Q Quarterly report2026-04-29

    Q1 2026 10-Q: revenue pressure persists after FY2025 loss

  4. DEF 14A Proxy statement2026-03-24

    2026 proxy (duplicate): annual meeting governance and comp items

  5. DEF 14A Proxy statement2026-03-24

    2026 proxy (duplicate): annual meeting governance and comp items

  6. 10-K Annual report2026-02-20

    FY2025 10-K: first net loss (-$882K), active members 26,650 vs 30,870

  7. 8-K Material agreement2026-02-17

    Signed $5.9M deal to buy back 25.5% of shares from Broady trusts at $2.00

  8. 8-K Earnings results2026-02-04

    Q4/FY2025 results: swung to a net loss; revenue -7.4% YoY

  9. 8-K Earnings results2025-11-05

    Q3 2025 10-Q: revenue and member counts continue to erode

Recent filings

all on EDGAR ↗
3Period ending 2026-05-072026-06-08open ↗8-KPeriod ending 2026-05-072026-05-07open ↗10-QPeriod ending 2026-03-312026-04-29open ↗8-KPeriod ending 2026-04-292026-04-29open ↗ARSPeriod ending 2025-12-312026-03-30open ↗DEF 14APeriod ending 2026-05-072026-03-24open ↗DEFA14AFiling2026-03-24open ↗DEF 14APeriod ending 2026-05-072026-03-24open ↗10-KPeriod ending 2025-12-312026-02-20open ↗SCHEDULE 13DFiling2026-02-18open ↗8-KPeriod ending 2026-02-172026-02-17open ↗8-KPeriod ending 2026-02-042026-02-04open ↗

Quality score

D
ValueGrowthProfitHealthMom.
ValueA+
GrowthF
ProfitabilityF
Financial healthC+
MomentumF
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
1.5552-week4.27
Revenue
$39.8M
-7.4% YoY
Net margin
-2.2%
ROE
-3.8%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$39.8M-7.4%
Net income-$882K-254.2%
Gross profit$29.3M-8.0%
Operating income-$1.81M-39.2%
Diluted EPS-$0.08-260.0%
Cash & equivalents$6.81M-49.7%
Total assets$38.4M-30.6%
Total liabilities$15.0M-33.3%
Stockholders' equity$23.4M-28.7%
Gross: 73.5%Op.: -4.5%L/E: 0.64x

Frequently asked

Is NATURAL HEALTH TRENDS CORP (NHTC) a buy?
NHTC currently carries a Sell rating with 3/5 conviction, derived from its latest SEC filings. A melting-ice-cube direct seller: statistically cheap but shrinking, cash-burning, and paying a dividend it can no longer afford.
What is NATURAL HEALTH TRENDS CORP's quality score?
NHTC scores 46.74136029411765/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000912061, latest 10-Q filed 2026-04-29) · EODHD · Proprietary analysis · as of 7/4/2026, 5:10:35 AM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 1:10 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2024-12-15
MASON RANDALL A
Director
Exercise1.66K
2024-12-15
MASON RANDALL A
Director
Disposed (D)1.66K @ $4.26$7.08K
2024-12-15
CHAN YIU TUNG
Director
Exercise1.30K
2024-12-15
CHAN YIU TUNG
Director
Disposed (D)1.30K @ $4.26$5.52K

Earnings history

beat/miss · move
2026-04-29—▲ +6.51%8-K ↗
2026-02-04—▲ +1.09%8-K ↗
2025-11-05—▼ -24.77%8-K ↗
2025-07-30—▲ +1.52%8-K ↗
2025-04-30—▲ +2.45%8-K ↗
2025-02-05—▲ +5.25%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score47 vs 67
Revenue growth-7.4% vs 7.5%
Net margin-2.2% vs 10.0%
Return on equity-3.8% vs 12.0%
P/E— vs 26.2